Lysophosphatidic Acid and Adenylyl Cyclase Inhibitor Increase Proliferation of Senescent Human Diploid Fibroblasts by Inhibiting Adenosine Monophosphate-Activated Protein Kinase

Abstract

This study was designed to elucidate the molecular mechanism underlying lysophosphatidic acid (LPA) and adenylyl cyclase inhibitor SQ22536 (ACI)-induced senescent human diploid fibroblast (HDF) proliferation. Because adenosine monophosphate (AMP)-activated protein kinase (AMPK) is known to inhibit cell proliferation, we examined the phosphorylation status of AMPK and p53 and the expression level of p21^waf1/cip1 after treating HDFs with LPA and ACI. Phosphorylation of AMPKα on threonine-172 (p-Thr172-AMPKα) increases its catalytic activity but phosphorylation on serine-485/491 (p-Ser485/491-AMPKα) reduces the accessibility of the Thr172 phosphorylation site thereby inhibiting its catalytic activity. LPA increased p-Ser485/491-AMPKα, presumably by activating cAMP-dependent protein kinase (PKA). However, ACI reduced p-Thr172-AMPKα by inhibiting the LKB signaling. Our data demonstrated that both LPA and ACI inhibit the catalytic activity of AMPKα and p53 by differentially regulating phosphorylation of AMPKα, causing increased senescent cell proliferation. These findings suggest that the proliferation potential of senescent HDFs can be modulated through the regulation of the AMPK signaling pathway.